A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with EstrogenReceptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Park, John (Associate Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research